A pharmaceutical company owns all of the marketable medicines for a disease. Due to the critical nature of the disease, and their market monopoly, they are able to charge extremely high prices for the drug. The shareholders are delighted with their returns but the CEO faces a(n) every day.

Quick computing currently sells 12 million computer chips each year at a price of $19 per chip. it is about to introduce a new chip, and it forecasts annual sales of 22 million of these improved chips at a price of $24 each. however, demand for the old chip will decrease, and sales of the old chip are expected to fall to 6 million per year. the old chips cost $10 each to manufacture, and the new ones will cost $14 each. what is the proper cash flow to use to evaluate the present value of the introduction of the new chip? (enter your answer in millions.)